Literature DB >> 23538980

Levels of patient activation among adults with schizophrenia: associations with hope, symptoms, medication adherence, and recovery attitudes.

Marina Kukla1, Michelle P Salyers, Paul H Lysaker.   

Abstract

Patient activation, defined as one's attitudes and confidence toward managing illness, has been not been thoroughly studied in consumers with schizophrenia. The current study sought to understand the relationship between patient activation and symptoms, medication adherence, recovery attitudes, and hope in a sample of 119 adults with schizophrenia. The participants were enrolled in an 18-month randomized controlled study of the Illness Management and Recovery program. Data were collected at baseline; correlations and stepwise multiple regressions were used to examine the relationships and determine the unique contribution of variables. Higher patient activation was most strongly associated with positive recovery attitudes, higher levels of hope, and fewer emotional discomfort symptoms. Patient activation was significantly related to a broad measure of illness self-management, providing evidence for the construct validity of the patient activation measure. Our findings emphasize the importance of recovery-based mental health services that recognize level of patient activation as a potential factor in consumer outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 23538980     DOI: 10.1097/NMD.0b013e318288e253

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  24 in total

1.  Why are you here again? Concordance between consumers and providers about the primary concern in recurring psychiatric visits.

Authors:  Kelsey A Bonfils; Sadaaki Fukui; Erin L Adams; Heidi M Hedrick; Michelle P Salyers
Journal:  Psychiatry Res       Date:  2014-07-31       Impact factor: 3.222

2.  Consumer factors predicting level of treatment response to illness management and recovery.

Authors:  Dominique A White; Alan B McGuire; Lauren Luther; Adrienne I Anderson; Peter Phalen; John H McGrew
Journal:  Psychiatr Rehabil J       Date:  2017-09-14

Review 3.  The Relationship Between Clinical and Personal Recovery in Patients With Schizophrenia Spectrum Disorders: A Systematic Review and Meta-analysis.

Authors:  Robin Michael Van Eck; Thijs Jan Burger; Astrid Vellinga; Frederike Schirmbeck; Lieuwe de Haan
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

4.  What Factors are Associated with Consumer Initiation of Shared Decision Making in Mental Health Visits?

Authors:  Marianne S Matthias; Sadaaki Fukui; Michelle P Salyers
Journal:  Adm Policy Ment Health       Date:  2017-01

5.  Correlates of observer-rated active involvement in psychiatric treatment visits.

Authors:  Kelsey A Bonfils; Lauren Luther; Sadaaki Fukui; Erin L Adams; Kimberly C Dreison; Ruth L Firmin; Michelle P Salyers
Journal:  Psychiatry Res       Date:  2017-07-01       Impact factor: 3.222

6.  Parenthood and severe mental illness: relationships with recovery.

Authors:  Kelsey A Bonfils; Erin L Adams; Ruth L Firmin; Laura M White; Michelle P Salyers
Journal:  Psychiatr Rehabil J       Date:  2014-05-12

7.  Patient Activation and Mental Health Care Experiences Among Women Veterans.

Authors:  Rachel Kimerling; Joanne Pavao; Ava Wong
Journal:  Adm Policy Ment Health       Date:  2016-07

8.  Peer Support: a Human Factor to Enhance Engagement in Digital Health Behavior Change Interventions.

Authors:  Karen L Fortuna; Jessica M Brooks; Emre Umucu; Robert Walker; Phillip I Chow
Journal:  J Technol Behav Sci       Date:  2019-05-29

9.  Sense of Belonging and Hope in the Lives of Persons with Schizophrenia.

Authors:  Jennifer K Barut; Mary S Dietrich; Paul A Zanoni; Sheila H Ridner
Journal:  Arch Psychiatr Nurs       Date:  2015-08-11       Impact factor: 2.218

10.  COVID-19 social distancing: negative effects on people with Parkinson disease and their associations with confidence for self-management.

Authors:  Galit Yogev-Seligmann; Michal Kafri
Journal:  BMC Neurol       Date:  2021-07-20       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.